Bringing the NAMs Revolution to Women's Health

Recent updates and view no how the FDA views New Approach Methodologies (NAMs) to improve data translatability from the lab to patients.

Previous
Previous

Application Note: Human Endometrial Organoids as a New Approach Methodology (NAM) for Preclinical Cytotoxicity Testing in Women’s Reproductive Health